Daniel T Scavilla, the President of $GMED ($GMED), sold 130,000 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares. Following this trade, they now own 0 shares of $GMED stock.
$GMED Insider Trading Activity
$GMED insiders have traded $GMED stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $GMED stock by insiders over the last 6 months:
- DANIEL T SCAVILLA (President, CEO) has traded it 2 times. They made 0 purchases and 2 sales, selling 190,000 shares.
- KELLY HULLER (SVP, GC, Corporate Secretary) has traded it 3 times. They made 0 purchases and 3 sales, selling 12,500 shares.
- DAVID D DAVIDAR has traded it 3 times. They made 0 purchases and 3 sales, selling 75,000 shares.
- ANN D RHOADS sold 15,000 shares.
- LESLIE V NORWALK sold 1,000 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GMED Hedge Fund Activity
We have seen 197 institutional investors add shares of $GMED stock to their portfolio, and 271 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VESTAL POINT CAPITAL, LP removed 900,000 shares (-100.0%) from their portfolio in Q3 2024
- CITADEL ADVISORS LLC added 806,296 shares (+103.3%) to their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 714,568 shares (-52.4%) from their portfolio in Q3 2024
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 671,821 shares (-27.2%) from their portfolio in Q3 2024
- WELLINGTON MANAGEMENT GROUP LLP removed 631,239 shares (-19.7%) from their portfolio in Q3 2024
- ARROWMARK COLORADO HOLDINGS LLC added 614,295 shares (+inf%) to their portfolio in Q3 2024
- LORD, ABBETT & CO. LLC added 530,451 shares (+inf%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
